COMMUNIQUÉS West-GlobeNewswire

The Ensign Group to Present at the Oppenheimer 28th Annual Healthcare Conference
14/03/2018
MISSION VIEJO, Calif., March 14, 2018 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (NASDAQ: ENSG ), the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, home health, home care, hospice [...]
Precision Therapeutics Increases Equity Stake in Helomics to 25%
14/03/2018
MINNEAPOLIS, March 14, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT ) (“Precision” or “the Company”), formerly Skyline Medical, a company focused on applying artificial intelligence to personalized [...]
Catalyst Pharmaceuticals Announces Fourth Quarter and Year-End 2017 Financial Results and Provides Corporate Update
14/03/2018
--Firdapse ® NDA to be Resubmitted Before the End of this Quarter --Significant Progress with MuSK-MG Regulatory and Clinical Program --$84M Year-End Cash and Investments --Company to Host Quarterly Conference Call at 5 [...]
Novavax Provides Corporate Update and Report of Fourth Quarter and Year-End 2017 Financial Results
14/03/2018
RSV Phase 3 Prepare™ Trial Outcome De-risked by Successful Informational Analysis NanoFlu™ Vaccine Demonstrates Improved Immune Responses Compared to Egg-Based, High-Dose Flu Vaccine John J. Trizzino Appointed Chief [...]
Inovio Pharmaceuticals Reports 2017 Fourth Quarter and Year End Financial Results
14/03/2018
PLYMOUTH MEETING, Pa., March 14, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO ) today reported financial results for the fourth quarter and year ended December 31, 2017. Total revenue was $8.8 [...]
Novavax Promotes John J. Trizzino to Expanded Role as Chief Business Officer and Chief Financial Officer
14/03/2018
GAITHERSBURG, Md., March 14, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq: NVAX ) today announced the promotion of John J. Trizzino to Senior Vice President, Chief Business Officer (CBO) and Chief Financial Officer ( [...]
miRagen Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update
14/03/2018
Data from Phase 1 clinical trial supports advancing cobomarsen, or MRG-106, into a Phase 2 potentially registrational clinical trial for CTCL (the SOLAR trial) Completed Phase 1 clinical trial of MRG-201 supports [...]
Sunesis Pharmaceuticals to Present at Upcoming Investor Conferences
14/03/2018
SOUTH SAN FRANCISCO, Calif., March 14, 2018 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS ) today announced that the Company will present at two upcoming investor conferences. Willie Quinn, Chief [...]
Carrie Arran Resources Announces Proposed Private Placement With Insider Participation
14/03/2018
TORONTO, March 14, 2018 (GLOBE NEWSWIRE) -- Carrie Arran Resources Inc. (the “ Corporation ”) is pleased to announce a proposed non-brokered private placement (the “ Private Placement ”) of up to 600,000 common shares [...]
Invuity Announces Proposed Public Offering of Common Stock
14/03/2018
SAN FRANCISCO, March 14, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ: IVTY ) ("Invuity" or the "Company"), a leading medical technology company focused on minimal access surgery, today announced that it intends to [...]
Aduro Biotech to Present at the 28th Annual Oppenheimer Healthcare Conference
14/03/2018
BERKELEY, Calif., March 14, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO ) today announced that Stephen T. Isaacs, chairman, president and chief executive officer of Aduro, will present at the 28th Annual [...]
Trevena to Present at the Oppenheimer & Company 28th Annual Healthcare Conference
14/03/2018
CHESTERBROOK, Pa., March 14, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ: TRVN ) today announced that it will be presenting at the Oppenheimer & Company 28th Annual Healthcare Conference on Wednesday, March 21, [...]
Immune Design Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update
14/03/2018
- New positive clinical and translational data for both lead agents - Strong balance sheet with 2017 year-end cash and equivalents of $144.2 Million - Conference call at 1:30 pm Pacific today SEATTLE and SOUTH SAN [...]
La Jolla Pharmaceutical Company Announces $100 Million Public Offering of Common Stock
14/03/2018
SAN DIEGO, March 14, 2018 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC ) (La Jolla), a leader in the development of innovative therapies intended to significantly improve outcomes in patients [...]
Arbutus Announces Corporate Update and Year-End 2017 Financial Results
14/03/2018
ARB-1467 Phase II Combination Study Beginning in 1Q18 Two New Drug Candidates Planned to Enter Clinical Development in 2H18 Over $200M in Cash Available to Fund Development of HBV Assets Company to Host a Corporate [...]
Capricor Presents Fourth Quarter and Full Year 2017 Financial Results and Corporate Update
14/03/2018
Planning to Initiate HOPE-2 Clinical Trial To Host Conference Call and Webcast Today at 4:30 p.m. ET LOS ANGELES, March 14, 2018 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR ), a clinical-stage biotechnology [...]
Interpace Diagnostics Announces Timing of Earnings Release and Investor Conference Call
14/03/2018
PARSIPPANY, N.J., March 14, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG ) (the “Company”), a fully integrated commercial and bioinformatics company that provides clinically useful molecular [...]
EDAP TMS SA : EDAP TMS to Announce Year End 2017 Financial Results on Tuesday, March 27, 2018
14/03/2018
LYON, France, March 14, 2018 - EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced that it will release its financial results for the year ended December 31, 2017, after the close of [...]
Virbac : operating profit from ordinary activities 2017 comparable to 2016
14/03/2018
Virbac: operating profit from ordinary activities 2017 comparable to 2016 Public release dated March 14, 2018 CONSOLIDATED DATA AS OF DECEMBER 31 st in € million 2017 2016 % change 2017/2016 Revenue from ordinary [...]

Pages